Pharmacology of lobeline, A nicotinic receptor ligand

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 410-419

  Damaj, M I ^a   Patrick, G S ^a   Creasy, K R ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTISINE; DIHYDRO BETA ERYTHROIDINE; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BINDING KINETICS; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HYPOTHERMIA; INTRATHECAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOKING CESSATION; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; LIGANDS; LOBELINE; MALE; MICE; MICE, INBRED ICR; NICOTINE; NICOTINIC AGONISTS; RATS;

EID: 0030867294     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ABOOD, L. G., SALLES, K. S. AND MAITI, A.: Structure-activity studies of carbamate and other esters: Agonists and antagonists to nicotine. Pharmacol. Biochem. Behav. 30: 403-408, 1988.
2. ACETO, M. D., MARTIN, B. R., UWAYDAH, I. M., MAY, E. L., HARRIS, L, S., IZAZOLA-CONDE, C., DEWEY, W. L. AND VINCEK, W. C.: Optically pure (+)-nicotine from (±)-nicotine and biological comparisons with (-)-nicotine. J. Med. Chem. 22: 174-177, 1979.
3. AIZENMAN, E., TANG, L.-H. AND REYNOLDS, I. J.: Effects of nicotinic agonists on the NMDA receptor. Brain Res. 551: 355-357, 1991.
4. BHAT, R. V., TURNER, S. L., SELVAAG, S. R., MARKS, M. J. AND COLLINS, A. C.: Regulation of brain nicotinic receptors by chronic agonist infusion. J. Neurochem. 56: 1932-1939, 1991.
5. BRIONI, J., O'NEILL, A., KIM, D. AND DECKER, M.: Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238: 1-8, 1993.
6. BRIONI, J. D., O'NEILL, A. B., KIM, D. J. B., BUCKLEY, M. J., DECKER, M. W. AND ARNERIC, S. P.: Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J. Pharmacol. Exp. Ther. 271: 353-361, 1994.
7. CAGGIULA, A., EPSTEIN, L., ANTELMAN, S., SAYLOR, S., KNOPF, S., PERKINS, K. AND STILLER, R.: Acute stress or corticosterone administration reduces responsiveness to nicotine: Implications for a mechanism of conditioned tolerance. Psychopharmacology 111: 499-507, 1993.
8. CAGGIULA, A. R., EPSTEIN, L. H., ANTELMAN, S. M., SAYLOR, S. S., PERKINS, K. A., KNOPF, S. AND STILLER, R.: Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol. Biochem. Behav. 40: 53-59, 1991.
9. CLARKE, P. B. S. AND REUBEN, M.: Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes form striatal [3Hl release. Br. J. Pharmacol. 117:595-606, 1996.
10. COURT, J. A., PIGGOTT, M. A. AND PERRY, E. K.: Nicotine reduces the binding of [3H]MK-801 to brain membranes, but not via the stimulation of high affinity nicotinic receptors. Brain Res. 524: 319-321, 1990.
11. D'AMOUR, F. E. AND SMITH, D. L.: A METHOD FOR DETERMINING LOSS or PAIN SENSATION. J. PHARMACOL. EXP. THER. 72: 74-79, 1941.
12. DAMAJ, M. I., WELCH, S. P. AND MARTIN, B. R.: Characterization and modulation of acute tolerance to nicotine in mice. J. Pharmacol. Exp. Ther. 277: 454-461, 1996.
13. DECKER, M., BUCKLEY, M. AND BRIONI, J.: Differential effects or pretreatment with nicotine and lobeline on nicotine-induced changes in body temperature and locomotor activity in mice. Drug Dev. Res. 31: 52-58, 1994.
14. DECKER, M., MAJCHRZAK, M. AND ARNERIC, S.: Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45: 571-576, 1993.
15. DEWEY, W. L., HARRIS, L. S., HOWES, J. S. AND NUITE, J. A.: The effect of various neurohormonal modulations on the activity of morphine and the narcotic antagonists in tail-flick and phenylquinone test. J. Pharmacol. Exp. Ther. 175: 435-442, 1970.
16. EPSTEIN, L. H., CAGGIULA, A. R. AND STILLER, R.: Environment-specific tolerance to nicotine. Psychopharmacology 97: 235-237, 1989.
17. FUDALA, P. AND IWAMOTO, E.: Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav. 25: 1041-1049, 1986.
18. GLASSCO, W., SUCHOCHI, J., GEORGE, C., MARTIN, B. AND MAY, E.: Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)-abd (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1h-pyrrolo-[3,2-h] isoquinoline, a structural nanlog of nicotine. J. Med. Chem. 36: 3381-3385, 1993.
19. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59: 848-856, 1992.
20. HYLDEN, J. L. AND WILCOX, G. L.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
21. KHAN, I. M., TAYLOR, P. AND YAKSH, T. L.: Cardiovascular and behavioral responses to nicotinic agents administered intrathecally. J. Pharmacol. Exp. Ther. 270: 150-158, 1994.
22. KOJIMA, H., COVERTON, P., SILVILOTTI, L., GIBB, A. J. AND COLQUHOUN, D.: Relative agonist potencies at neuronal nicotinic receptors: A comparison between ganglionic and recombinant receptors. Br. J. Pharmacol. 112: U183, 1994.
23. LEVIN, E. D.: Nicotinic systems and cognitive function. Psychopharmacology 108: 417-431, 1992.
24. 3H]-nicotine to a single class of hufg affinity sites in rat brain membranes. Mol. Pharmacol. 29: 448-454, 1986.
25. MARKS, M. J., STITZEL, J. A., ROMM, E., WEHNER, J. M. AND COLLINS, A. C.: Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and alpha-bungarotoxin. Mol. Pharmacol. 30: 427-436, 1986.
26. MARTIN, B. R.: Nicotine receptors in the central nervous system. In The Receptors, ed. by P. M. Conn, pp. 393-415, Academic Press, New York, 1986.
27. OLIN, B. R., HEBEL, S. K., GREMP, J. L. AND HULBERTT, M. K.: Smoking deterrents. In Drug Facts and Comparisons, ed. by B. R. Olin, S. K. Hebel, J. L. Gremp and M. K. Hulbertt, pp. 3087-3095, Lippincott Co., St. Louis, MO, 1995.
28. PATRICK, J. AND LUETJE, C.: Pharmacological diversity of nicotine receptors. In Biological Basis for Substance Abuse, ed. by S. G. Korenman and J. D. Barchas, pp. 81-95, Oxford University Press, NY, 1993.
29. PEREIRA, E. F. R., ALKONDON, M., REINHARDT, S., MAELICKE, A., PENG, X., LINDSTROM, J., WHITING, P. AND ALBUQUERQUE, E. X.: Physostigmine and galanthamine: probes for a novel binding site on the α4β2 subtype of neuronal nicotinic acetylcholine receptors satbly expressed in fibroblast cells. J. Pharmacol. Exp. Ther. 270: 768-778, 1994.
30. REAVILL, C., JENNER, P., KUMAR, R. AND STOLERMAN, I. P.: High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology 27: 235-241, 1988.
31. REAVILL, C., WALTHER, B., STOLERMAN, I. P. AND TESTA, B.: Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29: 619-624, 1990.
32. SCHRATTENHOLZ, A., PEREIRA, E., ROTH, U., WEBER, K., ALBUQUERQUE, E. AND MAELICKEL, A.: Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49: 1-6, 1996.
33. 3H]nicotine binding to mouse brain homogenate. J. Pharm. Pharmacol. 40: 793-797, 1988.
34. SLOAN, J. W., MARTIN, W. R., BOSTWICK, M., HOOK, R. AND WALA, E.: The comparative binding characteristics of nicotine ligands and their pharmacology. Pharmacol. Biochem. Behav. 30: 255-267, 1988.
35. STOLERMAN, I. P., GARCHA, J. AND MIRZA, N. R.: Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117: 430-437, 1995.
36. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacological Calculations with Computer Programs, Springer-Verlag, New York, 1987.
37. TERRY, A. V., BUCCAFUSCO, J. J., JACKSON, W. J., ZAGRODNIK, S., EVANS-MARTIN, F. F. AND DECKER, M, W.: Effects of stimulation or blockade of central nicotiniccholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology 123: 172-181, 1996.
38. VOLLE, R. AND REYNOLDS, L.: Receptor desensitization by lobeline and nicotine. Naunym-Schmied Arch. Pharmacol. 276: 49-54, 1973.